Quitcool is an atypical antipsychotic indicated for the treatment of ①Schizophrenia ②Bipolar disorder, manic episodes ③Bipolar disorder, depressive episodes. Quitcool is Quetiapine tablets for oral use produced by Hikma Pharmaceuticals.
Black Box WARNING
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA RELATED PSYCHOSIS: Elderly patients with dementia_related psychosis treated with antipsychotic drugs are at an increased risk of death. Quitcool is not approved for elderly patients with dementia.
SUICIDAL THOUGHTS AND BEHAVIORS:Increased risk of suicidal thoughts and behavior in children, adolescents and young adults taking antidepressants. Patients should be monitored for worsening and emergence of suicidal thoughts and behaviors.
What is Quitcool? And what is it used for?
Quitcool Tablets contain a substance called Quetiapine. This belongs to a group of medicines called atypical antipsychotics. Quitcool Tablets can be used to treat several illnesses, such as:
Quitcool is Quetiapine generic by Hikma Pharmaceuticals
Your doctor may continue to prescribe Quitcool tablets even when you are feeling better.
Quitcool is local alternative for Seroquel
How to take Quitcool Tablets?
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Your doctor will decide on your starting dose. The maintenance dose (daily dose) will depend on your illness and needs but will usually be between 150 mg and 800 mg.
Dosage and administration
Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia Adults
Schizophrenia Adolescents (13-17 years)
Bipolar Mania Adults Monotherapy or as an adjunct to lithium or divalproex
Bipolar Mania Children and Adolescents (10 to 17 years), Monotherapy
Bipolar Depression Adults
Warnings and Precautions
Cerebrovascular Adverse Reactions: Increased incidence of cerebrovascular adverse reactions (e.g., stroke, transient ischemic attack) has been seen in elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs.
Neuroleptic Malignant Syndrome (NMS): Manage with immediate discontinuation and close monitoring.
Metabolic Changes: Atypical antipsychotics have been associated with metabolic changes. These metabolic changes include hyperglycemia, dyslipidemia, and weight gain.
Hyperglycemia and Diabetes Mellitus: Monitor patients for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. Monitor glucose regularly in patients with diabetes or at risk for diabetes.
Dyslipidemia: Undesirable alterations have been observed in patients treated with atypical antipsychotics. Appropriate clinical monitoring is recommended. including fasting blood lipid testing at the beginning of, and periodically, during treatment .
Weight Gain: Gain in body weight has been observed; clinical monitoring of weight is recommended.
Tardive Dyskinesia: Discontinue if clinically appropriate.
Hypotension: Use with caution in patients with known cardiovascular or cerebrovascular disease.
Increased Blood Pressure in Children and Adolescents: Monitor blood pressure at the beginning of, and periodically during treatment in children and adolescents.
Leukopenia, Neutropenia and Agranulocytosis: Monitor complete blood count frequently during the first few months of treatment in patients with a pre-existing low white cell count or a history of leukopenia/neutropenia and discontinue Quitcool at the first sign of a decline in WBC in absence of other causative factors.
Cataracts: Lens changes have been observed in patients during long-term quetiapine treatment. Lens examination is recommended when starting treatment and at 6-month intervals during chronic treatment .
Anticholinergic (antimuscarinic) Effects: Use with caution with other anticholinergic drugs and in patients with urinary retention, prostatic hypertrophy, constipation, and increased intraocular pressure.
Possible Side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Discontinuation symptoms
Discontinuation symptoms (symptoms which occur when you stop taking Quitcool) include:
كويتكول… معلومات لغة عربية، أنقر هنا
Quitcool- FAQ
Is Quitcool a good sleep aid? Quitcool is not approved as sleeping pills. Quetiapine, the active ingredient, has been officially approved in Canada for schizophrenia, bipolar disorder and major depression only. Quetiapine is sedating and makes people drowsy.
Is Quitcool good for anxiety? Studies suggested that the antipsychotic drug Quitcool may help battle major depression and generalized anxiety disorder. Quitcool is already approved to treat schizophrenia and bipolar disorder (formerly called manic-depressive illness).
Does Quitcool work immediately? Sedative effects happen almost immediately; however, it may take up to two to three weeks to see some improvement in other symptoms and up to six weeks for the full effects to be seen.
Is Quitcool a mood stabilizer? Quitcool is effective mood stabilizers, clinically used to treat mania and depression, while preventing recurrence and improving quality of life.
Is Quitcool physically addictive? Quetiapine(Quitcool) is an atypical or second-generation antipsychotic agent and has been a subject of a series of case reports and suggested to have the potential for misuse or abuse. However, it is not a controlled substance and is not generally considered addictive.